Your browser doesn't support javascript.
loading
PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use population.
Frye, Laura J; Buhimschi, Irina A; Raymond, Elizabeth G; Zhao, Guomao; Winikoff, Beverly.
Afiliação
  • Frye LJ; Gynuity Health Projects, 220 East 42nd Street New York, NY 10017, USA.
  • Buhimschi IA; Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612, USA.
  • Raymond EG; Gynuity Health Projects, 220 East 42nd Street New York, NY 10017, USA.
  • Zhao G; Department of Obstetrics & Gynecology, University of Illinois at Chicago College of Medicine, Chicago, IL 60612, USA.
  • Winikoff B; Gynuity Health Projects, 220 East 42nd Street New York, NY 10017, USA.
Biomark Med ; 17(2): 73-85, 2023 01.
Article em En | MEDLINE | ID: mdl-37038980
In the USA, abortion with pills is an option for people with pregnancies of less than 71 days. Usually, people use ultrasound to find out how far along a pregnancy is. Ultrasound can be pricey and hard to find. Some studies show that a protein in blood, called PAPP-A, may be another option. The authors took blood from and did ultrasounds for people who wanted an abortion. They measured how much PAPP-A was in the blood using two different methods. The level of PAPP-A in the blood did a good job of distinguishing pregnancies that were higher and lower than 71 days.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Plasmática A Associada à Gravidez / Aborto Induzido Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Biomark Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Plasmática A Associada à Gravidez / Aborto Induzido Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: Biomark Med Ano de publicação: 2023 Tipo de documento: Article